For a broader discussion of whether GLP-1 treatment is a good fit overall, our article on whether GLP-1 is bad for you provides helpful context
Borthwick Diabetes Research Centre, Lister Hospital, Coreys Mill Ln, Stevenage SG1 4AB, UK Tel: +44-1438-285972, Fax: +44-1438-284150, E-mail: [email protected] Copyright 2024 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
G., Contreras, V., Menini, T., & Gugliucci, A
Prior to Wegovys FDA approval for obesity, there were approximately 190,000 approved claims for GLP-1 medications to treat obesity each month